TG Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.

About TGTX

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. 

CEO
Michael Sean Weiss
CEOMichael Sean Weiss
Employees
286
Employees286
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1993
Founded1993
Employees
286
Employees286

TGTX Key Statistics

Market cap
919.58M
Market cap919.58M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.64M
Average volume2.64M
High today
$6.40
High today$6.40
Low today
$6.10
Low today$6.10
Open price
$6.19
Open price$6.19
Volume
650.67K
Volume650.67K
52 Week high
$35.94
52 Week high$35.94
52 Week low
$3.48
52 Week low$3.48

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
0%
Sell
25%

TGTX Earnings

-$0.71
-$0.47
-$0.24
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.